ISN-KDIGO Webinar: Improving CKD Quality of Care

Chronic kidney disease (CKD) affects over 850 million people globally, and the need to prevent its development and progression is urgent. During the past decade, new perspectives have arisen related to the quality and precision of care for CKD, owing to the development of new tools and interventions for CKD diagnosis and management. New biomarkers, imaging methods, artificial intelligence techniques, and approaches to organizing and delivering healthcare may help clinicians recognize CKD, determine its etiology, assess the dominant mechanisms at given time points, and identify patients at high risk for progression or related events. As opportunities to apply the concepts of precision medicine for CKD identification and management continue to be developed, an ongoing discussion of the potential implications for care delivery is required. The 2022 KDIGO Controversies Conference on Improving CKD Quality of Care: Trends and Perspectives examined and discussed best practices for improving the precision of CKD diagnosis and prognosis, managing the complications of CKD, enhancing the safety of care, and maximizing patient quality of life. Existing tools and interventions currently available for the diagnosis and treatment of CKD were identified, with discussion of current barriers to their implementation and strategies for improving the quality of care delivered for CKD. Key knowledge gaps and areas for research were also identified.

 Learning objectives:

- Discuss perspectives on optimal practices for the diagnosis of CKD
- Outline emerging methods for determining CKD diagnosis and prognosis
- Delineate the barriers for implementation and strategies for improving the quality of care for CKD globally 

Further reading:

Gregorio Obrador Vera


Roberto Pecoits-Filho


Dr. Pecoits-Filho is a Senior Research Scientist at Arbor Research Collaborative for Health in Michigan, USA and a Professor of Medicine, Pontifical Catholic University of ParanĂ¡ in Curitiba, Brazil. He is the current (2021-23) Chair of the Education Committee of the International Society of Nephrology. As a clinician, he has broad activities in Internal Medicine and Nephrology based at the University affiliated hospitals, where he was the Chief of the Department of Internal Medicine between 2010 and 2016, the Director of the Residency program in Nephrology from 2013 to 2016. Dr. Pecoits-Filho is the Principal Investigator for the study CKDOPPS, a multinational study on practice patterns and outcomes in chronic kidney disease and act as a Scientific Leader for clinical trials in the Americas with George Clinical. Dr. Pecoits-Filho received his MD and trained in Internal Medicine and Nephrology in Curitiba, Brazil before completing a nephrology research fellowship at the University of Missouri, Columbia and a PhD from the University of Sao Paulo. He was a visiting scholar for extended periods at the Karolinska Institute (Sweden) and the George Institute (Australia), and has participated as a principal investigator, regional leader and in steering committees in multinational clinical trials. Dr. Pecoits-Filho served as a member of the Executive Committee of the International Society of Nephrology (ISN) (2017-2019), the SONG Initiative (2017-present) and KDIGO (2016-2018).

Holly Kramer



ISN-KDIGO Webinar: Improving CKD Quality of Care
Open to view video.
Open to view video.